Enhabit, Inc. (EHAB) Stock Price

EHABStock
$0.00+30.43%52W
Market Cap—
P/E—
PEG Ratio—
Div yield—
Beta0.53

EHAB Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)67.37%
Price vs S&P 500 (4W)-4.77%
VGM Score56.13

EHAB Earnings Surprise History

QuarterReport dateEPS estimateEPS actualSurprise
Q1 2026$0.15$0.17+9.30%(+$0.01)
Q4 2025$0.14$0.14-1.33%(+$0.00)
Q3 2025$0.12$0.17+42.39%(+$0.05)
Q2 2025$0.10$0.13+30.80%(+$0.03)

EHAB Analyst Recommendations

Jun 2026
Jul 2026
Aug 2026
Sep 2026
2.55
2.55
2.55
2.55

Industry Peers — Home Health Care(7)

SymbolValue ScoreGrowth ScoreMomentum ScoreP/E Ratio (Annual)Revenue Growth TTM (YoY)Operating Margin (TTM)ROE (TTM)Price
EHABEnhabit, Inc.
BDB—2.4%1.5%-0.8%$0.00
BTSGBrightSpring Health Services, Inc. Common StockCBC63.2x19.9%3.1%19.0%$60.87
CHEChemed CorporationDDB25.2x3.3%13.5%29.4%$512.38
OPCHOption Care Health, Inc. Common StockBCB22.5x6.0%5.9%15.8%$31.20
AVAHAveanna Healthcare Holdings Inc. Common StockCBB12.0x19.5%10.3%149.8%$12.34
ADUSAddus HomeCare Corp.CCC22.6x15.9%10.0%9.6%$115.98
AHCOAdaptHealth Corp. Common StockACD13.6x-0.4%-4.5%-15.2%$6.02
BTSGUBrightSpring Health Services, Inc. Tangible Equity UnitCBC63.2x19.9%3.1%19.0%$197.90

About Enhabit, Inc.

Enhabit Inc operates a diversified home healthcare platform providing Medicare-certified home health and hospice services across the United States. The company's Home Health segment, its primary revenue driver, delivers a comprehensive suite of clinical services including skilled nursing, physical therapy, occupational therapy, speech therapy, and home health aide services to adult patients. Complementing this offering, its Hospice segment provides specialized care for patients with life-limiting illnesses, focusing on symptom management and quality of life rather than curative treatment.